SEPTIN7P11: A Potential Drug Target and Biomarker (G441601)

Target Name: SEPTIN7P11

NCBI ID: G441601

SEPTIN7P11

Other Name(s): Septin 7 pseudogene 11 | septin 7 pseudogene 11

SEPTIN7P11: A Potential Drug Target and Biomarker

SEPTIN7P11 is a protein that belongs to the SEPIN family, which is known for their role in cell signaling and membrane structure. The SEPIN family has been implicated in various diseases, including cancer, neurodegenerative diseases, and developmental disorders. Despite its importance, much is Still unknown about this protein. However, recent studies have suggested that SEPTIN7P11 may have potential as a drug target or biomarker.

SEPTIN7P11's Structure and Function

SEPTIN7P11 is a 21-kDa protein that is expressed in various tissues, including brain, heart, and pancreas. It is composed of a N-terminal transmembrane region, a coiled C-terminal region, and an C-terminal cytoplasmic tail. The transmembrane region contains a single extracellular domain, which is responsible for the protein's ability to interact with various signaling molecules. The coiled C-terminal region contains a unique feature, known as a hypervariable region (HVR), which is involved in the protein's stability and localization to the cell surface. The C-terminal cytoplasmic tail is composed of a series of unique repeats, known as the SEPIN-type repeats, which are involved in the protein's stability and interactions with other proteins.

SEPTIN7P11's Potential as a Drug Target

SEPTIN7P11 has been suggested as a potential drug target due to its involvement in various signaling pathways. The SEPIN family is known for its role in intracellular signaling, and SEPTIN7P11 has been shown to play a role in regulating the trafficking of various signaling molecules to the cell surface. This suggests that SEPTIN7P11 may be a useful target for drugs that are designed to modulate intracellular signaling pathways.

One of the promising aspects of SEPTIN7P11 as a drug target is its potential to treat various neurological and psychiatric disorders, such as Alzheimer's disease, Parkinson's disease, and depression. These disorders are characterized by the accumulation of neurodegenerate proteins, which can cause the progressive loss of brain cells and lead to the development of various symptoms. SEPTIN7P11 has been shown to play a role in the regulation of neurodegenerate protein trafficking to the cell surface, which suggests that it may be a useful target for drugs that are designed to treat these disorders.

SEPTIN7P11 has also been shown to be involved in various signaling pathways that are involved in cancer progression. SEPIN7P11 has been shown to play a role in the regulation of the delivery of adhesion molecules to the cell surface, which is a critical step in the development of cancer cells. Additionally, SEPIN7P11 has been shown to play a role in the regulation of angiogenesis, which is the process by which new blood vessels are formed in the tumor. This suggests that SEPTIN7P11 may be a useful target for drugs that are designed to inhibit the growth and progression of cancer cells.

SEPTIN7P11's Potential as a Biomarker

SEPTIN7P11 may also be used as a biomarker for various diseases. The SEPIN family has been shown to play a role in the regulation of various signaling pathways, and this suggests that SEPTIN7P11 may be involved in the regulation of various physiological processes. may be a useful biomarker for diseases that are characterized by the disruption of these signaling pathways.

One of the promising aspects of SEPTIN7P11 as a biomarker is its potential to diagnose various diseases, such as cancer. The disruption of SEPIN7P11's signaling pathway has

Protein Name: Septin 7 Pseudogene 11

The "SEPTIN7P11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SEPTIN7P11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets